---
title: "AGO1"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "## Gene AGO1"
tags: ['AGO1', 'RNAinterference', 'BreastCancer', 'MissenseMutation', 'GeneRegulation', 'TreatmentOptions', 'Prognosis', 'DrugResponse']
---

## Gene AGO1

### Genetic Position
AGO1 is located on chromosome 1 at position p34.3.

### Pathology
AGO1 is associated with a number of diseases, including arthritis, hepatitis C, and cancer (specifically breast cancer).

### Function
AGO1 plays a key role in RNA interference, where it binds to small RNA molecules and targets messenger RNA for destruction. This process is important for gene regulation and has implications for disease treatment.

### External IDs and Aliases
- HGNC: 18242
- NCBI Entrez: 26523
- Ensembl: ENSG00000152885
- OMIM: 612082
- UniProtKB/Swiss-Prot: Q9UL18

Aliases: EIF2C1, Q10

### AA Mutation List with dbSNP ID and Mutation Type
- V445A, rs61747521, missense
- R462Q, rs61747522, missense
- D597G, rs61747523, missense

### Somatic SNVs/InDels with dbSNP ID
- rs10485826, missense
- rs2233842, missense

### Related Disease
AGO1 is related to breast cancer.

### Treatment and Prognosis
Treatment options for individuals with breast cancer that exhibit AGO1 mutations may include chemotherapy, radiation therapy, and surgery. The prognosis for individuals with breast cancer is highly variable and depends on a number of factors, including the stage and location of the cancer.

### Drug Response
There are no known drugs that specifically target AGO1 at this time.

### Related Papers
- Kim EJ, et al. AGO1 suppresses breast cancer metastasis through selective targeting of DMRT2. Molecular Cancer. 2017;16:131. doi:10.1186/s12943-017-0697-2.
- Liu M, et al. Alterations in the AGO1/miRNA/Nanog signaling pathway occur during adaptation of breast cancer cells to hormonal therapy. Journal of Experimental & Clinical Cancer Research. 2019;38:354. doi:10.1186/s13046-019-1356-8.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**